INSTITUT CURIE
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Private
- Established
- 1909-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.curie.fr
ProActIF-01 Trial: Randomized Study of Evaluation of an Individualized Program of Nutrition and Adapted Physical Activity in Frail Patients With Advanced Lung or Digestive Cancers
- First Posted Date
- 2022-07-01
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 273
- Registration Number
- NCT05441163
- Locations
- 🇫🇷
Institut Bergonié, Bordeaux, France
🇫🇷Centre de Lutte Contre le Cancer Jean Perrin, Clermont-Ferrand, France
🇫🇷centre Léon Bérard, Lyon, France
Opioid Free Versus Opioid Based Anaesthesia for Free Flap Reconstruction Surgery of the Breast: A Phase III Multicentric Randomized Controlled Study.
- First Posted Date
- 2022-06-30
- Last Posted Date
- 2024-04-05
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 158
- Registration Number
- NCT05439005
- Locations
- 🇫🇷
Institut Curie Saint-Cloud, Saint-Cloud, France
🇫🇷Gustave Roussy, Cancer Campus, Grand Paris, Villejuif, France
🇫🇷Institut Curie Paris, Paris, France
AsiDNA Children, Adolescents and Young Adults
- First Posted Date
- 2022-05-27
- Last Posted Date
- 2023-12-26
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 8
- Registration Number
- NCT05394558
- Locations
- 🇫🇷
Chu Nancy, Nancy, France
🇫🇷Chu Strasbourg, Strasbourg, France
🇫🇷Chu Toulouse, Toulouse, France
Exploration of Adaptive Antitumoral Immune Cells Through Lymphapheresis in Cancer Patients : ALCYTA
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-04-29
- Last Posted Date
- 2023-12-26
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 300
- Registration Number
- NCT05354765
- Locations
- 🇫🇷
Institut Curie, Saint-Cloud, France
Consultation to Announce the End of Chemotherapy and Specific Treatments in an Outpatient Setting: Evaluation of the Psychological Impact and Information Exchange.
Completed
- Conditions
- First Posted Date
- 2022-03-24
- Last Posted Date
- 2023-12-19
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 40
- Registration Number
- NCT05293925
- Locations
- 🇫🇷
Institut Curie, Paris, France
Efficacy and Safety of Pembrolizumab in Combination With Lenvatinib in Metastatic Uveal MElanoma Patients (PLUME)
Phase 2
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-03-16
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 51
- Registration Number
- NCT05282901
- Locations
- 🇫🇷
Institut Curie, Paris, France
Impact of Forearm Free Flap in Orbital Exenteration Reconstruction
- Conditions
- First Posted Date
- 2022-02-24
- Last Posted Date
- 2022-03-11
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 72
- Registration Number
- NCT05255315
- Locations
- 🇫🇷
Institut Curie, Paris, France
SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-01-14
- Last Posted Date
- 2024-04-18
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 600
- Registration Number
- NCT05192980
- Locations
- 🇫🇷
Hôpital des enfants, Bordeaux, France
🇫🇷Hôpital Arnaud de Villeneuve, Montpellier, France
🇫🇷CHU NICE, Nice, France
Comparative Study of Diagnostic and Prognosis Biomarkers of Prostate Cancer in Liquid Biopsy
- First Posted Date
- 2021-12-02
- Last Posted Date
- 2024-04-18
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 80
- Registration Number
- NCT05141383
- Locations
- 🇫🇷
Institut Curie, Paris, France
Analysis of Circulating Tumor mArkers in Blood 4 - ALCINA 4
- First Posted Date
- 2021-10-21
- Last Posted Date
- 2024-07-29
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 2050
- Registration Number
- NCT05088395
- Locations
- 🇫🇷
Institut Curie, Saint-cloud, France
© Copyright 2024. All Rights Reserved by MedPath